Display options
Share it on

Chronic Stress (Thousand Oaks). 2019 Jan-Dec;3. doi: 10.1177/2470547019865267. Epub 2019 Aug 30.

Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder.

Chronic stress (Thousand Oaks, Calif.)

Sage M Comstock, Jatin G Vaidya, Mark J Niciu

Affiliations

  1. Department of Psychiatry, Iowa Neuroscience Institute, University of Iowa Health Care, Iowa City, IA, USA.

PMID: 31511840 PMCID: PMC6738944 DOI: 10.1177/2470547019865267

Abstract

A family history of an alcohol use disorder (AUD) has been shown to increase one's risk of developing an AUD. Additionally, a positive family history of AUD (family history positive (FHP)) has neurobiological and neuropsychopharmacological consequences, and this review summarizes differential drug response as well as neuroanatomical and neurocognitive correlates. FHP status is related to altered responses to a number of drugs, including substances with abuse liability like alcohol, opioids, amphetamines, and ketamine. FHP individuals demonstrate fewer aversive effects and more rewarding response to both alcohol and subanesthetic dose ketamine. Ketamine is a rapid-acting antidepressant, and several studies have reported that ketamine is more effective for FHP treatment-resistant depressed individuals. In short, the reviewed neurophysiological differences may contribute to ketamine's enhanced antidepressant efficacy in FHP patients. Volumetric differences in the amygdala, nucleus accumbens, neocortex, and cerebellum are commonly reported. Furthermore, FHP has also been associated with altered neurocognitive performance, e.g., increased impulsivity. The imaging and psychological literature supports a neurodevelopmental lag hypothesis in FHP youth. The review will further discuss these findings in depth.

Keywords: familial alcoholism; family history of alcohol dependence; ketamine; neuroimaging; treatment-resistant depression

Conflict of interest statement

Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Psychopharmacology (Berl). 2014 Jun;231(12):2385-93 - PubMed
  2. Psychol Med. 2004 Nov;34(8):1519-30 - PubMed
  3. PLoS One. 2014 Feb 04;9(2):e88188 - PubMed
  4. J Stud Alcohol. 1985 Jul;46(4):289-97 - PubMed
  5. Alcohol Clin Exp Res. 2002 Jun;26(6):827-35 - PubMed
  6. Alcohol Clin Exp Res. 2011 Aug;35(8):1426-34 - PubMed
  7. Alcohol Clin Exp Res. 2013 Mar;37(3):390-8 - PubMed
  8. Pharmacol Biochem Behav. 2011 Oct;99(4):696-703 - PubMed
  9. Addiction. 2008 Aug;103(8):1308-19 - PubMed
  10. Neuroimage Clin. 2017 Dec 12;17:1036-1046 - PubMed
  11. Hum Brain Mapp. 2014 Dec;35(12):5877-87 - PubMed
  12. Front Integr Neurosci. 2013 Mar 11;7:9 - PubMed
  13. Arch Gen Psychiatry. 1998 Nov;55(11):973-9 - PubMed
  14. Neuropsychopharmacology. 2013 Sep;38(10):1854-63 - PubMed
  15. J Stud Alcohol Drugs. 2015 Jan;76(1):47-56 - PubMed
  16. Biol Psychiatry. 2007 Sep 15;62(6):694-7 - PubMed
  17. J Stud Alcohol. 1993 Mar;54(2):219-24 - PubMed
  18. Bipolar Disord. 2012 Dec;14(8):880-7 - PubMed
  19. Drug Alcohol Depend. 2018 Apr 1;185:198-206 - PubMed
  20. Drug Alcohol Depend. 2010 Apr 1;108(1-2):1-6 - PubMed
  21. Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14259-64 - PubMed
  22. Alcohol Clin Exp Res. 2012 Apr;36(4):604-15 - PubMed
  23. Drug Alcohol Depend. 2012 Jun 1;123(1-3):98-104 - PubMed
  24. World J Biol Psychiatry. 2012 Jan;13(1):75-81 - PubMed
  25. Biol Psychiatry. 2007 Jun 1;61(11):1306-9 - PubMed
  26. J Stud Alcohol. 2000 Nov;61(6):827-35 - PubMed
  27. Psychiatry Res. 2011 Dec 30;194(3):304-313 - PubMed
  28. Addict Biol. 2017 Jan;22(1):218-228 - PubMed
  29. Neuropsychol Rev. 2010 Mar;20(1):1-20 - PubMed
  30. J Affect Disord. 2017 Jan 15;208:560-566 - PubMed
  31. Alcohol Clin Exp Res. 2002 Apr;26(4):441-8 - PubMed
  32. Alcohol Clin Exp Res. 2014 Dec;38(12):2944-51 - PubMed
  33. J Stud Alcohol. 2003 Mar;64(2):195-9 - PubMed
  34. Arch Gen Psychiatry. 1981 Aug;38(8):861-8 - PubMed
  35. Arch Gen Psychiatry. 2003 Jul;60(7):727-35 - PubMed
  36. Alcohol Clin Exp Res. 2012 Dec;36(12):2017-27 - PubMed
  37. Am J Psychiatry. 2004 Oct;161(10):1776-82 - PubMed
  38. Biol Psychiatry. 2011 Apr 1;69(7):675-83 - PubMed
  39. Psychiatry Res. 2005 Feb 28;138(2):115-30 - PubMed
  40. Clin Pharmacokinet. 2016 Sep;55(9):1059-77 - PubMed
  41. Drug Alcohol Depend. 2014 Nov 1;144:170-7 - PubMed
  42. J Clin Psychiatry. 2014 May;75(5):e417-23 - PubMed
  43. Am J Psychiatry. 1994 Feb;151(2):184-9 - PubMed
  44. J Psychiatr Res. 2011 Jul;45(7):980-8 - PubMed
  45. J Stud Alcohol Drugs. 2013 Mar;74(2):245-57 - PubMed
  46. Alcohol Clin Exp Res. 2002 Aug;26(8):1299-306 - PubMed
  47. Pharmacol Rev. 2018 Jul;70(3):621-660 - PubMed
  48. Addict Biol. 2007 Mar;12(1):122-32 - PubMed
  49. Alcohol Clin Exp Res. 2006 May;30(5):763-73 - PubMed
  50. Alcohol Clin Exp Res. 2003 Nov;27(11):1743-9 - PubMed
  51. Drug Alcohol Depend. 2011 Sep 1;117(2-3):198-203 - PubMed
  52. Psychol Med. 2017 Oct;47(13):2288-2301 - PubMed
  53. Drug Alcohol Depend. 2009 Feb 1;100(1-2):17-23 - PubMed
  54. Cerebellum. 2016 Dec;15(6):744-754 - PubMed
  55. Neurosci Lett. 2018 Apr 3;671:1-6 - PubMed
  56. Psychol Med. 2015 Apr;45(5):1061-72 - PubMed
  57. Alcohol Clin Exp Res. 1994 Aug;18(4):861-6 - PubMed
  58. Int J Neuropsychopharmacol. 2014 Oct 31;18(1): - PubMed
  59. Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E161-71 - PubMed
  60. Neuroimage. 2011 Feb 14;54(4):2582-9 - PubMed
  61. Exp Clin Psychopharmacol. 2001 Feb;9(1):101-9 - PubMed
  62. Drug Alcohol Depend. 2015 May 1;150:38-45 - PubMed
  63. Biol Psychiatry. 2009 Jan 15;65(2):181-4 - PubMed
  64. JAMA Psychiatry. 2017 Sep 1;74(9):911-923 - PubMed
  65. Alcohol Clin Exp Res. 2006 Aug;30(8):1308-14 - PubMed
  66. Neuroimage. 2010 Mar;50(1):267-76 - PubMed
  67. Addiction. 2012 Oct;107(10):1774-85 - PubMed
  68. J Neuroophthalmol. 2005 Sep;25(3):217-26 - PubMed
  69. Psychol Addict Behav. 2001 Sep;15(3):204-9 - PubMed
  70. Science. 1984 Sep 28;225(4669):1493-6 - PubMed
  71. Biol Psychiatry. 2007 Jan 1;61(1):41-7 - PubMed
  72. Dev Psychopathol. 2005 Summer;17(3):785-806 - PubMed
  73. Alcohol Clin Exp Res. 2014 Jun;38(6):1639-45 - PubMed
  74. Addict Behav. 2003 Aug;28(6):1129-39 - PubMed
  75. Biol Psychiatry. 2001 Jun 1;49(11):894-905 - PubMed
  76. Psychol Med. 2014 Oct;44(13):2775-86 - PubMed
  77. Psychiatr Pol. 2014 Jan-Feb;48(1):35-47 - PubMed
  78. Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E356-63 - PubMed
  79. World J Biol Psychiatry. 2013 Dec;14(8):565-73 - PubMed
  80. Biol Psychiatry. 2016 May 1;79(9):e69-e70 - PubMed
  81. Am J Drug Alcohol Abuse. 2010 May;36(3):161-7 - PubMed
  82. Dev Cogn Neurosci. 2015 Dec;16:147-154 - PubMed
  83. Am J Drug Alcohol Abuse. 2017 Jan;43(1):24-43 - PubMed
  84. Alcohol Clin Exp Res. 2018 Jan;42(1):89-99 - PubMed
  85. Neuropsychopharmacology. 2019 May;44(6):1076-1083 - PubMed
  86. Neuropsychopharmacology. 2015 Jan;40(2):412-20 - PubMed
  87. J Alcohol Drug Depend. 2013 Dec 12;Suppl 1: - PubMed
  88. Alcohol Clin Exp Res. 1985 Dec;9(6):498-502 - PubMed

Publication Types

Grant support